ICML 2017 | An overview of the current treatment landscape of non-Hodgkin lymphoma
Franco Cavalli, MD, FRCP, from the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, President of the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland, gives an overview of the current treatment landscape of non-Hodgkin lymphoma. Prof. Cavalli describes the tremendous progress made in the treatment of lymphoma over recent years, taking it from an incurable disease to a treatable condition. Discussing the various disease subtypes, Prof. Cavalli talks about the clinical challenges and the various treatments available. Looking to the future, novel therapies and precision medicine are the ways forward in the treatment of non-Hodgkin lymphoma.
This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
- b- cell
- checkpoint inhibitor
- checkpoint inhibitors
- cure rate
- ICML 2017 Non-Hodgkin Lymphoma
- precision medicine
- treatment landscape
Get great new content delivered to your inboxSign up